Price Capital Management, Inc. - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
Price Capital Management, Inc. ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$210,000
-84.4%
3,300
-84.9%
0.13%
-89.1%
Q4 2014$1,348,00021,8411.19%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
BB BIOTECH AG 7,202,585$270,385,00014.71%
DOWLING & YAHNKE LLC 675,798$25,369,0003.98%
GARRISON BRADFORD & ASSOCIATES INC 100,700$3,780,0003.87%
WILLIAM HARRIS INVESTORS INC 312,834$11,743,0003.67%
Meditor Group Ltd 490,000$18,395,0002.59%
AVALON CAPITAL MANAGEMENT 50,943$1,912,0001.89%
Orinda Asset Management LLC 14,665$551,0001.73%
PINNACLE ASSOCIATES LTD 2,064,760$77,511,0001.60%
PERKINS CAPITAL MANAGEMENT INC 52,850$1,984,0001.43%
NCM Capital Advisers, Inc. 24,950$937,0001.04%
View complete list of ISIS PHARMACEUTICALS INC shareholders